nVision is an early-stage medical device company dedicated to filling the void in female health-related innovation. Our current focus is to develop a technology that can be used in the office of the gynecologist to detect ovarian cancer & tube blockage.

nVision Medical was acquired by Boston Scientific in a $275 million dollar deal on April 15, 2018.
VIEW DETAILS